Show simple item record

dc.contributor.advisorEghdam Zamiri, Reza
dc.contributor.authorFatemi Zonouz, Mohammadreza
dc.date.accessioned2020-11-14T06:26:58Z
dc.date.available2020-11-14T06:26:58Z
dc.date.issued2020en_US
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/63032
dc.description.abstractIntroduction: Breast cancer is one of the leading causes of death among women worldwide. Although survival rates have improved in recent years due to early detection and more effective treatments, many breast cancers are not diagnosed early. Therefore, identifying relevant and suspicious markers will lead to early detection, better prognosis, and more effective cancer treatment in the future. HSP-70 is a type of HSP that may be a proinflammatory cytokine that leads to tissue damage in this disease. Considering that all the studies have been prepared from the serum of patients with breast cancer and no study has been done on the salivary HSP-70 level in these patients, also, preparing people's saliva is morally non-invasive compared to preparing their serum. Therefore, this study was designed and performed to evaluate the diagnostic value of HSP-70 levels in the saliva of these patients. Materials and Methods: In this study, 45 patients with breast cancer referred to the chemotherapy and radiotherapy wards of Shahid Madani Hospital in Tabriz from March 1998 to August 2010 and 45 healthy individuals were evaluated. After taking saliva samples from patients and healthy individuals during the mentioned period, salivary HSP-70 was measured using ELISA method and HANGZHOU kit. Mann-Whitney test was used to compare the level of HSP-70 between healthy and sick people, as well as to compare this marker in patients with positive and negative axillary lymph node involvement. The sensitivity, specificity and diagnostic value of this protein were also evaluated through ROC curve and cut-of-point determination; the software used in this study was SPSS 25 and P value less than 0.05 was considered significant. Results: The mean age of patients were (52.13 ± 6.56 years) and the mean age of healthy individuals were (53.62 ± 8.40 years). The mean salivary HSP70 was obtained in patients (8.82 ± 15.41 ng / ml) and in healthy individuals (6.28 15 15.03 ng / ml). (0.05 p <); Also, the sub-curved area of the ROC diagram was 0.497 Conclusion: The results of this study showed that salivary HSP70 levels in patients with breast cancer were not significantly different from salivary HSP70 levels in healthy individuals and according to the ROC curve, salivary levels of this protein do not have a good diagnostic function to identify healthy and sick people.en_US
dc.language.isofaen_US
dc.publisherTabriz University of Medical Sciences, School of Dentistryen_US
dc.relation.isversionofhttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/63031
dc.subjectCarcinoma, Breast cancer, HSP70, Axillary node lymph node involvementen_US
dc.titleEvaluation of the diagnostic value of salivary heat shock protein (HSP70) in patients with breast canceren_US
dc.typeThesisen_US
dc.contributor.supervisorMotahari, Parya
dc.identifier.docno603482en_US
dc.identifier.callno64002en_US
dc.contributor.departmentOral Pathologyen_US
dc.description.disciplineDentistryen_US
dc.description.degreeDDS degreeen_US
dc.citation.reviewerKhademnrzhad, Sahar
dc.citation.reviewerPourzare, Solmaz
dc.citation.reviewerPakdel, Farzaneh
dc.citation.reviewerBahloli, Sepideh
dc.citation.reviewerKohsoltani, Maryam
dc.citation.reviewerEslami, Hosein


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record